King’s College London, along with collaborators including Zoe Global Limited, Harvard Medical School, Massachusetts General Hospital and Stanford Hospital, have launched a global observational clinical trial based on a free monitoring app called the ‘COVID-19 Symptom...
Kings College London
Category
Kaiser Permanente Participates Pathbreaking Study to Better Understand Genetics of Near Sightedness
Kaiser Permanente investigators are looking into the underlying genetic factors behind near-sightedness or myopia. The team has closed in on the specific genes contributing to myopia risk. In a study led by Kings College London, a U.S and UK-based team leveraged...
King’s College London Licenses its Investigational Digital Therapy for Irritable Bowell Syndrome to SF-Based Startup
Kings College London, a leading research center and one of the oldest and most prestigious universities in England, has inked a worldwide exclusive licensing deal for the very new innovative digital therapeutic intellectual property (IP) it developed for the treatment...
Parkinson’s UK & King’s College London Plan Pioneering Clinical Trial to Treat Psychosis in Parkinson’s Patients Using Cannabidiol
Parkinson’s UK, the largest charitable funder of Parkinson’s research in Europe, has partnered with investigators at King’s College London to invest £1.2 million in a pioneering Phase II clinical trial investigating the use of cannabidiol (CBD)—a compound found...
Kings College London: A Novel Gene Therapy Addressing Recessive Dystrophic Epidermolysis Bullosa (RDEB) Shows Promise
King’s College London, in collaboration with University College, London conducted a Phase I clinical trials focused on recessive dystrophic epidermolysis bullosa (RDEB), a severe form of blistering skin disease caused by mutations in COL7A1 gene. The UK-based study...